Starpharma Holdings Limited
SPHRF
$0.084
$0.00020.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 23.12% | -0.20% | -595.99% | 0.47% |
| Total Depreciation and Amortization | -2.77% | 0.39% | 0.22% | -3.18% | -0.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.75% | 366.56% | -0.20% | -142.91% | -0.46% |
| Change in Net Operating Assets | -- | -- | -0.22% | -- | -- |
| Cash from Operations | 2.75% | 77.64% | -0.20% | -536.51% | -0.48% |
| Capital Expenditure | 2.88% | 60.61% | -0.38% | -806.90% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.88% | 60.61% | -0.38% | -806.90% | 0.00% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | -114.29% | 0.00% | 90.47% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.76% | -369.58% | 0.23% | 107.77% | 0.48% |
| Foreign Exchange rate Adjustments | 0.00% | 50.00% | -2.56% | -343.75% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.75% | 64.26% | -0.21% | -190.29% | 0.48% |